Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Orpea Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

OrpeaDer Gewinn des Unternehmens wird voraussichtlich um 72.4% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 6.7% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich wachsen um 12.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -7.3% betragen.

Wichtige Informationen

-72.4%

Wachstumsrate der Gewinne

12.1%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	24.0%
Wachstumsrate der Einnahmen	6.7%
Zukünftige Eigenkapitalrendite	-7.3%
Analystenabdeckung	Low
Zuletzt aktualisiert	15 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

LSE:0NEX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	6,349	136	1,180	710	1
12/31/2025	5,994	-175	810	626	2
12/31/2024	5,631	-292	408	390	2
12/31/2023	5,198	1,355	217	366	N/A
9/30/2023	5,062	-1,387	95	308	N/A
6/30/2023	4,926	-4,128	-493	250	N/A
3/31/2023	4,803	-4,078	-357	330	N/A
12/31/2022	4,681	-4,027	245	410	N/A
9/30/2022	4,602	-2,167	433	560	N/A
6/30/2022	4,524	-307	621	711	N/A
3/31/2022	4,411	-121	476	732	N/A
12/31/2021	4,299	65	332	754	N/A
9/30/2021	4,193	127	261	760	N/A
6/30/2021	4,088	189	191	766	N/A
3/31/2021	4,005	175	237	772	N/A
12/31/2020	3,922	160	283	778	N/A
9/30/2020	3,863	176	391	813	N/A
6/30/2020	3,804	192	499	848	N/A
3/31/2020	3,772	213	515	827	N/A
12/31/2019	3,740	234	530	806	N/A
9/30/2019	3,661	231	466	698	N/A
6/30/2019	3,581	227	401	590	N/A
3/31/2019	3,501	224	276	503	N/A
12/31/2018	3,420	220	151	415	N/A
9/30/2018	3,356	230	102	417	N/A
6/30/2018	3,292	239	52	419	N/A
3/31/2018	3,215	164	143	409	N/A
12/31/2017	3,138	90	233	398	N/A
9/30/2017	3,062	133	N/A	386	N/A
6/30/2017	2,986	176	N/A	374	N/A
3/31/2017	2,914	235	N/A	360	N/A
12/31/2016	2,841	294	N/A	347	N/A
9/30/2016	2,745	220	N/A	342	N/A
6/30/2016	2,650	147	N/A	337	N/A
3/31/2016	2,521	137	N/A	325	N/A
12/31/2015	2,392	127	N/A	314	N/A
9/30/2015	2,286	128	N/A	310	N/A
6/30/2015	2,180	130	N/A	306	N/A
3/31/2015	2,064	126	N/A	298	N/A
12/31/2014	1,949	121	N/A	290	N/A
9/30/2014	1,832	112	N/A	274	N/A
6/30/2014	1,716	103	N/A	258	N/A
3/31/2014	1,662	108	N/A	253	N/A
12/31/2013	1,608	114	N/A	247	N/A
9/30/2013	1,567	109	N/A	234	N/A
6/30/2013	1,527	103	N/A	221	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 0NEXFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-72.4% pro Jahr).

Ertrag vs. Markt: 0NEXFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-72.4% pro Jahr).

Hohe Wachstumserträge: 0NEXFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: 0NEXDie Einnahmen des Unternehmens (6.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (3.8% pro Jahr).

Hohe Wachstumseinnahmen: 0NEXDie Einnahmen des Unternehmens (6.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 0NEX wird voraussichtlich in 3 Jahren unrentabel sein.

Orpea Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Orpea SA Provides Earnings Guidance for the Full Year 2023; Provides Consolidated Revenue Guidance for the Years 2024 and 2025

Orpea SA Provides Financial Guidance for 2023

Orpea Sa Announces Revenue Guidance for Year Ending 31 December 2022

Orpea Provides Earnings Guidance for the Full Year 2021

Orpea SA Reiterate Revenue Guidance for the Full Year of Fiscal 2021

Recent updates

Orpea SA, Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: EPS: €0.13 (vs €62,330 loss in FY 2022)

New major risk - Share price stability

Orpea SA has completed a Follow-on Equity Offering in the amount of €390.019673 million.

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea Sa Appoints Méka Brunel as Independent Non-Executive Director

Orpea SA has filed a Follow-on Equity Offering in the amount of €1.2 billion.

New major risk - Shareholder dilution

New major risk - Market cap size

Now 83% undervalued after recent price drop

Orpea SA(ENXTPA:ORPDS) dropped from SBF 120 Index

Orpea SA has filed a Follow-on Equity Offering in the amount of €3.884212 billion.

Orpea SA, Annual General Meeting, Dec 22, 2023

New major risk - Share price stability

Orpea SA Provides Earnings Guidance for the Full Year 2023; Provides Consolidated Revenue Guidance for the Years 2024 and 2025

First half 2023 earnings released: €5.74 loss per share (vs €4.17 loss in 1H 2022)

New minor risk - Financial position

New major risk - Revenue and earnings growth

Orpea SA to Report First Half, 2023 Results on Oct 11, 2023

An Unknown buyer acquired portfolio of four recently built retirement homes In Austria from Orpea SA (ENXTPA:ORP) for €55 million.

An Unknown buyer acquired portfolio of four recently built retirement homes In Austria from Orpea SA (ENXTPA:ORP) for €55 million.

Orpea SA Provides Financial Guidance for 2023

Now 25% undervalued after recent price drop

New major risk - Negative shareholders equity

Full year 2022 earnings released: €62.33 loss per share (vs €1.01 profit in FY 2021)

Adoro SIA signed an agreement to acquire Retirement Home and Entire Scope of Activities in Latvia from Orpea SA (ENXTPA:ORP).

Caisse des Dépôts et Consignations and a representative group of creditors agreed to acquire a 50.2% stake in Carver Maritime Manatee.

Now 28% undervalued after recent price drop

Orpea Sa Announces Revenue Guidance for Year Ending 31 December 2022

First half 2022 earnings released: EPS: €0 (vs €1.59 in 1H 2021)

Orpea SA(ENXTPA:ORP) dropped from FTSE All-World Index (USD)

Orpea S.A Appoints Laure Duhot as Non-Executive Director

Investor sentiment deteriorated over the past week

Syntrus Achmea Real Estate & Finance signed agreement to acquire portfolio of 32 retirement homes located in the Netherlands from Orpea SA (ENXTPA:ORP) for EUR 125 million.

ORPEA Announces Major Changes in its Board of Directors

Full year 2021 earnings released: EPS: €1.01 (vs €2.48 in FY 2020)

Orpea SA to Report First Half, 2022 Results on Sep 21, 2022

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

ORPEA Appoints Laurent Guillot as CEO

Investor sentiment improved over the past week

Orpea Announces CEO Changes

Investor sentiment deteriorated over the past week

Orpea Provides Earnings Guidance for the Full Year 2021

First half 2021 earnings released

Upcoming dividend of €0.90 per share

Orpea SA Reiterate Revenue Guidance for the Full Year of Fiscal 2021

Full year 2020 earnings released

Orpea SA Proposes Dividend for Financial Year 2020

New 90-day low: €103

Orpea SA to Report Fiscal Year 2020 Results on Mar 16, 2021

New 90-day high: €118

New 90-day high: €109

ORPEA Société Anonyme (ENXTPA:ORP) agreed to acquire remaining 55% stake in Groupe Sinoue - Sarl.

Orpea SA (ENXTPA:ORP) acquired 50% stake in Brindley Healthcare Limited.

New 90-day low: €96.70

New 90-day low - €98.22

New 90-day high - €110

Icade SA (ENXTPA : ICAD) agreed to acquire Portfolio of 9 Healthcare Facilities in Germany & France from Orpea SA (ENXTPA : ORP) for €145 million.

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken